Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-05-22

Clinical Trial Update: Influence Of Different Airflow Resistances On Drug Effect Of 50μg Salmeterol And 6 μg Formoterol [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial conducted by GlaxoSmithKline assessed how different inhalation airflow resistances influence the effects of Salmeterol 50 μg and Formot…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Formoterol (formoterol)
  • Salmeterol (salmeterol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 4 | Status: COMPLETED